North Haven-based healthcare products maker Covidien Ltd. is a suing a competitor for allegedly infringing on one of Covidien’s patents.
Covidien said it filed suit in Delaware federal court against Davol Inc., a subsidiary of C.R. Bard, claiming Davol’s brand of mesh fixation and applicator device breached Covidien’s  U.S. Patent No. 6,562,051.
“We will vigorously protect our intellectual property,” said Covidien executive Dave Motley.
The patent generally relates to a system for controllably discharging fasteners from an applicator. Covidien asked the court to ban Davol from continuing to make and sell its Sorbafix device, as well as for compensatory damages.
